Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.010
Buy
RSI(14)
50.547
Neutral
STOCH(KDJ)(9,3,3)
39.521
Sell
ATR(14)
0.097
High Vlolatility
CCI(14)
11.932
Neutral
Williams %R
63.415
Sell
TRIX(12,20)
0.500
Sell
StochRSI(14)
0.000
Oversold
Search
Sharps Technology Inc
STSSAdd to Watchlist
1.880USD
-0.120-6.00%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
79.57MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Sharps Technology Inc
Currency: USD Updated: 2026-05-15Key Insights
Sharps Technology Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 161 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 22.00.In the medium term, the stock price is expected to remain stable.The company has shown average stock market performance over the past month, with weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sharps Technology Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Sharps Technology Inc Highlights
StrengthsRisks
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Growing
The company is in a growing phase, with the latest annual income totaling USD 7.01M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 7.01M.
Fairly Valued
The company’s latest PE is -0.17, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 12.23M shares, increasing 42.03% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 20.80K shares of this stock.
Analyst Rating
Based on
0
analysts
--
Current Rating
22.000
Target Price
+877.78%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-15The current financial score of Sharps Technology Inc is 5.56, ranking 195 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low.
Score
Financials
6.79
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
6.50
Operational Efficiency
2.84
Growth Potential
4.56
Shareholder Returns
7.08
Sharps Technology Inc's Company Valuation
Currency: USD Updated: 2026-05-15The current valuation score of Sharps Technology Inc is 8.43, ranking 21 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.17, which is -100.83% below the recent high of 0.00 and -590852.43% above the recent low of -995.16.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 161/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-15No earnings forecast score is currently available for Sharps Technology Inc. The Healthcare Equipment & Supplies industry's average is 7.80. The average price target is 22.00, with a high of 22.00 and a low of 22.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
No Data
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-15The current price momentum score of Sharps Technology Inc is 1.02, ranking 206 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 2.10 and the support level at 1.69, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
1.986
Sell
MA10
1.941
Sell
MA20
1.885
Sell
MA50
1.801
Buy
MA100
1.899
Sell
MA200
3.794
Sell
Institutional Confidence
Currency: USD Updated: 2026-05-15Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-15The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Sharps Technology Inc is 1.67, ranking 179 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 2.05. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
2.04
VaR
--
240-Day Maximum Drawdown
+91.11%
240-Day Volatility
+137.24%
Return
Best Daily Return
60 days
+9.71%
120 days
+15.79%
5 years
--
Worst Daily Return
60 days
-7.36%
120 days
-27.03%
5 years
--
Sharpe Ratio
60 days
+0.63
120 days
-0.48
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+91.11%
3 years
+99.98%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.52
3 years
-0.33
5 years
--
Skewness
240 days
+3.18
3 years
+3.28
5 years
--
Volatility
Realised Volatility
240 days
+137.24%
5 years
--
Standardised True Range
240 days
+25.92%
5 years
--
Downside Risk-Adjusted Return
120 days
-59.38%
240 days
-59.38%
Maximum Daily Upside Volatility
60 days
+55.68%
Maximum Daily Downside Volatility
60 days
+38.63%
Liquidity
Average Turnover Rate
60 days
+32.39%
120 days
+43.83%
5 years
--
Turnover Deviation
20 days
-100.00%
60 days
-100.00%
120 days
-99.99%
Peer Comparison
Healthcare Equipment & Supplies
Sharps Technology Inc
STSS
3.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
BRKR
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
